Rheumatologists practicing in the current healthcare environment are experiencing unprecedented information flow, data management issues, and a rise in quality designations and pay-for-performance incentive programs. There is increasing pressure on rheumatologists to document or capture treatment concordance with guideline recommendations and best practices and to monitor gaps in care and patient outcomes. Unfortunately, some quality programs are not considered clinically meaningful, and even those that are often bring administrative burdens related to reporting, data aggregation, and analysis.